首页> 外文期刊>Investigative ophthalmology & visual science >Response to anti-VEGF-A treatment in co-cultured endothelial and retinal pigment epithelial cells
【24h】

Response to anti-VEGF-A treatment in co-cultured endothelial and retinal pigment epithelial cells

机译:共培养内皮和视网膜色素上皮细胞对抗VEGF-A治疗的反应

获取原文
           

摘要

Purpose: Anti-VEGF molecules Ranibizumab (RA) and Aflibercept (AF) are widely employed to treat neovascular maculopathies. Blockage of secreted VEGF-A, however, may be associated to an increased expression and secretion of other VEGF family members. The aim of this study is to investigate the impact of RA and AF in an in vitro model of interacting RPE and endothelial cells. Methods: Human RPE (ARPE-19) and endothelial (HECV) cells were co-cultured in DMEM (1 g/L glucose) and 10% FBS. Cells were treated with clinical doses of either RA (0.125 mg/ml) or AF (0.5 mg/ml) for 24 (T1) and 72 (T2) hours, then drugs were removed and cells were co-cultured for further 48 hours (T3). At every experimental timepoint we evaluated: cell viability (via fluorimetric assay); mRNA expression (via RealTime-PCR) and secretion of VEGF-A, -B, -C and PlGf (via ELISA); influence of conditioned media on endothelial cell migration and proliferation (Scratch assay).br / Results: Cell viability was not affected by exposure to RA or AF. At T3 viability of HECV remained unaffected, whilst viability of ARPE-19 cells was significantly increased either with RA or AF compared to control cells. mRNA expression of VEGFs was differently regulated in ARPE-19 and HECV: i.e. VEGF-A (T1) is decreased by RA in RPE, but not in HECV; VEGF-A (T2) is increased by AF only in HECV; HIF-1?± (T3) is decreased by both RA and AF in RPE, but not in HECV. VEGF-A was not detectable in surpernatants of cells cultured with RA or AF, and remained very low even at T3. Levels of VEGF-B were not affected by RA nor AF. Levels of VEGF-C is slightly increased at T1, and returned to controlsa?? level at T2. Levels of PlGF was very low in cells grown with AF at every time points. Scratch assay showed that wound healing was prevented by media collected from AF (T1), RA and AF (T2), and AF (T3).br / Conclusions: These findings suggest that at clinical dose RA and AF do not exert a cytotoxic effect on RPE and endothelial cells. However, significant functional changes have been observed in both cell lines as revealed by RT-PCR and ELISA. Therefore the results suggest that the concentrations of different VEGFs in the media contribute to establishing an anti-angiogenic environment, which can be maintained even after drug removal. The strongest inhibition of endothelial cells migration was reached with media collected from RA (T2).
机译:目的:抗VEGF分子雷珠单抗(RA)和阿柏西普(AF)被广泛用于治疗新血管斑块病。然而,分泌的VEGF-A的阻断可能与其他VEGF家族成员的表达和分泌增加有关。这项研究的目的是研究RA和AF在RPE和内皮细胞相互作用的体外模型中的影响。方法:将人RPE(ARPE-19)和内皮细胞(HECV)在DMEM(1 g / L葡萄糖)和10%FBS中共培养。用RA(0.125 mg / ml)或AF(0.5 mg / ml)的临床剂量处理细胞24(T1)和72(T2)小时,然后取出药物,将细胞再培养48小时( T3)。在每个实验时间点,我们评估:细胞活力(通过荧光测定); mRNA表达(通过RealTime-PCR)和VEGF-A,-B,-C和PlGf的分泌(通过ELISA);条件培养基对内皮细胞迁移和增殖的影响(划痕试验)。
结果:暴露于RA或AF不会影响细胞活力。在T3时,与对照细胞相比,RA或AF使ARPE-19细胞的存活率不受HECV的影响而显着增加。在ARPE-19和HECV中,VEGF的mRNA表达受到不同的调节:即,RA在RPE中可降低VEGF-A(T1),而在HECV中则不。 VEGF-A(T2)仅在AF中增加。 RA和AF在RPE中均会降低HIF-1α±(T3),而在HECV中则不会。在用RA或AF培养的细胞的上清液中检测不到VEGF-A,即使在T3时也很低。 VEGF-B的水平不受RA或AF的影响。 VEGF-C的水平在T1时略有增加,并返回到对照组。在T2的水平。在每个时间点,用AF生长的细胞中PlGF的水平都非常低。刮擦试验表明,从AF(T1),RA和AF(T2)以及AF(T3)收集的介质阻止了伤口愈合。
结论:这些发现表明,在临床剂量下,RA和AF不会发挥作用。对RPE和内皮细胞有细胞毒性作用。然而,如RT-PCR和ELISA所揭示,在两种细胞系中都观察到了显着的功能变化。因此,结果表明培养基中不同VEGF的浓度有助于建立抗血管生成环境,即使在去除药物后也可以维持这种环境。从RA(T2)收集的培养基对内皮细胞迁移的抑制作用最强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号